Targeted inhibition of mammalian target of rapamycin (mTOR) enhances radiosensitivity in pancreatic carcinoma cells
Open Access
- 1 March 2013
- journal article
- Published by Taylor & Francis Ltd in Drug Design, Development and Therapy
- Vol. ume 7, 149-159
- https://doi.org/10.2147/dddt.s42390
Abstract
Targeted inhibition of mammalian target of rapamycin (mTOR) enhances radiosensitivity in pancreatic carcinoma cells Zhi-Jun Dai,1,* Jie Gao,2,* Hua-Feng Kang,1,* Yu-Guang Ma,1 Xiao-Bin Ma,1 Wang-Feng Lu,1 Shuai Lin,1 Hong-Bing Ma,1 Xi-Jing Wang,1 Wen-Ying Wu3 1Department of Oncology, 2Department of Nephrology, 3Department of Pharmacology, Second Affiliated Hospital, Medical School of Xi'an Jiaotong University, Xi'an, People's Republic of China *These authors contributed equally to this work The mammalian target of rapamycin (mTOR) is a protein kinase that regulates protein translation, cell growth, and apoptosis. Rapamycin (RPM), a specific inhibitor of mTOR, exhibits potent and broad in vitro and in vivo antitumor activity against leukemia, breast cancer, and melanoma. Recent studies showing that RPM sensitizes cancers to chemotherapy and radiation therapy have attracted considerable attention. This study aimed to examine the radiosensitizing effect of RPM in vitro, as well as its mechanism of action. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and colony formation assay showed that 10 nmol/L to 15 nmol/L of RPM had a radiosensitizing effects on pancreatic carcinoma cells in vitro. Furthermore, a low dose of RPM induced autophagy and reduced the number of S-phase cells. When radiation treatment was combined with RPM, the PC-2 cell cycle arrested in the G2/M phase of the cell cycle. Complementary DNA (cDNA) microarray and reverse transcription polymerase chain reaction (RT-PCR) revealed that the expression of DDB1, RAD51, and XRCC5 were downregulated, whereas the expression of PCNA and ABCC4 were upregulated in PC-2 cells. The results demonstrated that RPM effectively enhanced the radiosensitivity of pancreatic carcinoma cells. Keywords: radiation; pancreatic carcinoma; mTOR; rapamycinKeywords
This publication has 55 references indexed in Scilit:
- RAD001 Inhibits Human Ovarian Cancer Cell Proliferation, Enhances Cisplatin-Induced Apoptosis, and Prolongs Survival in an Ovarian Cancer ModelClinical Cancer Research, 2007
- Recruitment of DNA repair synthesis machinery to sites of DNA damage/repair in living human cellsNucleic Acids Research, 2007
- Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitroExperimental Cell Research, 2004
- Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549Life Sciences, 2004
- DNA damage repair and transcriptionCellular and Molecular Life Sciences, 2004
- Role of cell cycle in mediating sensitivity to radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy.2002
- Paeoniae Radix, a Chinese herbal extract, inhibit hepatoma cells growth by inducing apoptosis in a p53 independent pathwayLife Sciences, 2002
- Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factorNature Medicine, 2002
- Analysis of Gene Transcription in Cells Lacking DNA-PK ActivityRadiation Research, 2001